Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Nature Clinical Practice. Nephrology|December 21, 2007
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failureKarien van der Putten, Branko Braam, Kim E Jie, et al.
Frontiers in Bioscience (Landmark Edition)|June 2, 2012
The role of melatonin treatment in chronic kidney diseaseMarije Russcher, Birgit Koch, Elsbeth Nagtegaal, et al.
The International Journal of Artificial Organs|December 19, 2009
Hemoglobin variability in patients with chronic kidney disease in the NetherlandsKarien van der Putten, Frederieke H van der Baan, Huub Schellekens, et al.
Neuro Endocrinology Letters|May 10, 2011
The role of renal function loss on circadian misalignment of cytokines EPO, IGF-1, IL-6 and TNF-alfa in chronic renal diseaseKarien van der Putten, Birgit Koch, Eus van Someren, et al.
European Journal of Heart Failure|May 25, 2010
High cumulative incidence of cancer in patients with cardio-renal-anaemia syndromeNicolas F Schroten, Karien van der Putten, Frans H Rutten, et al.
European Journal of Heart Failure|July 6, 2010
Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patientsKarien van der Putten, Kim E Jie, Daan van den Broek, et al.
Heart (British Cardiac Society)|November 13, 2010
Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndromeKim E Jie, Karien van der Putten, Marloes W T Bergevoet, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2009
Impairment of endogenous melatonin rhythm is related to the degree of chronic kidney disease (CREAM study)Birgit C P Koch, Karien van der Putten, Eus J W Van Someren, et al.
Pageof 2